Celularity Inc.
CELU
$2.04
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -52.64% | -22.17% | 49.70% | 145.54% | 312.22% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -52.64% | -22.17% | 49.70% | 145.54% | 312.22% |
| Cost of Revenue | 146.91% | 116.71% | -23.58% | 7.80% | 164.71% |
| Gross Profit | -95.05% | -39.64% | 331.04% | 2,841.85% | 367.60% |
| SG&A Expenses | -20.58% | 1.67% | 22.88% | 17.70% | 24.02% |
| Depreciation & Amortization | -18.42% | -32.60% | -32.01% | -32.19% | -16.48% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.08% | -0.66% | 20.24% | 3.67% | -2.16% |
| Operating Income | -55.91% | -42.16% | 12.66% | 29.28% | 48.71% |
| Income Before Tax | -277.99% | 10.26% | -239.09% | 82.85% | 86.47% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -277.99% | 10.26% | -239.24% | 82.85% | 86.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -277.99% | 10.26% | -239.24% | 82.85% | 86.47% |
| EBIT | -55.91% | -42.16% | 12.66% | 29.28% | 48.71% |
| EBITDA | -71.54% | -65.75% | 11.15% | 30.98% | 53.31% |
| EPS Basic | -243.89% | 18.23% | -219.86% | 85.31% | 89.07% |
| Normalized Basic EPS | -232.12% | 29.82% | -204.20% | -23.56% | 78.80% |
| EPS Diluted | -243.89% | 18.23% | -219.86% | 85.31% | 89.07% |
| Normalized Diluted EPS | -232.12% | 29.82% | -204.20% | -23.56% | 78.80% |
| Average Basic Shares Outstanding | 9.93% | 9.75% | 16.16% | 16.70% | 23.75% |
| Average Diluted Shares Outstanding | 9.93% | 9.75% | 16.16% | 16.70% | 23.75% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |